Skip to main content
letter
. 2008 Sep 23;99(9):1534–1538. doi: 10.1038/sj.bjc.6604687

Table 2. BRCA1/2 mutation status and CYP1A2*1F genotypes in the women included in the study. CYP1A2*1F genotypes were missing for two women from non-BRCA1/2 families.

  All women N=269 N CYP1A2*1F A/A N=136 N (%) CYP1A2*1F any C N=131 N (%)
BRCA1      
 Carrier 29 11 (37.9) 18 (621)
 Non-carrier 49 29 (59.2) 20 (40.8)
 Not tested 16 8 (50.0) 8 (50.0)
       
BRCA2      
 Carrier 7 4 (57.1) 3 (42.9)
 Non-carrier 7 6 (85.7) 1 (14.3)
 Not tested 4 3 (75.0) 1 (25.0)
       
Non-BRCA1/2 112 55 (50.0) 55 (50.0)
Untested families 45 20 (44.4) 25 (55.6)